|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,632.00 GBX | -0.79% |
|
+2.16% | -1.15% |
| 11:36pm | Daiichi Sankyo, AstraZeneca get US approvals for Enhertu | AN |
| 05-17 | AstraZeneca's Breast Cancer Treatment Lands US FDA Nod for Two New Indications | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | -0.79% | +2.16% | -1.15% | +31.97% | +72.67% | 282B |  | |  |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition